Optimal period for the prophylactic administration of neutrophil elastase inhibitor for patients with esophageal cancer undergoing esophagectomy

World Journal of Surgery

Volumn 35, Issue 7, 2011, Pages 1573-1579

  Iwahashi, Makoto ^a   Nakamori, Mikihito ^a   Nakamura, Masaki ^a   Ojima, Toshiyasu ^a   Naka, Teiji ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GLYCINE; LEUKOCYTE ELASTASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SIVELESTAT; SULFONAMIDE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; LUNG DISEASE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; TIME;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GLYCINE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; TIME FACTORS;

EID: 80051546730     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1095-6     Document Type: Conference Paper

References (20)

1. T Kakegawa 2003 Forty years' experience in surgical treatment for esophageal cancer Int J Clin Oncol 8 277 288 14586752 10.1007/s10147-003-0335-7 (Pubitemid 37370252)
2. M Nakamura M Iwahashi M Nakamori, et al. 2008 An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer Langenbecks Arch Surg 393 127 133 18071746 10.1007/s00423-007-0253-7
3. HJ Stein JR Siewert 2004 Improved prognosis of resected esophageal cancer World J Surg 28 520 525 15366737 10.1007/s00268-004-7417-1 (Pubitemid 38802785)
4. BP Whooley S Law SC Murthy, et al. 2001 Analysis of reduced death and complication rates after esophageal resection Ann Surg 233 338 344 11224620 10.1097/00000658-200103000-00006 1:STN:280:DC%2BD3M7ps1elsA%3D%3D (Pubitemid 32187811)
5. SH Bailey DA Bull DH Harpole, et al. 2003 Outcomes after esophagectomy: a ten-year prospective cohort Ann Thorac Surg 75 217 222 12537219 10.1016/S0003-4975(02)04368-0 (Pubitemid 36099051)
6. W Fang H Kato Y Tachimori, et al. 2003 Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer Ann Thorac Surg 76 903 908 12963226 10.1016/S0003-4975(03)00549-6 (Pubitemid 37100770)
7. S Law KH Wong KF Kwok, et al. 2004 Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer Ann Surg 240 791 800 15492560 10.1097/01.sla.0000143123.24556.1c (Pubitemid 39425771)
8. N Sato K Koeda K Ikeda, et al. 2002 Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer Ann Surg 236 184 190 12170023 10.1097/00000658-200208000-00006 (Pubitemid 34809537)
9. N Sato K Koeda Y Kimura, et al. 2001 Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery Eur Surg Res 33 279 284 11684834 10.1159/000049718 1:CAS:528:DC%2BD3MXnvVCks7c%3D (Pubitemid 34701888)
10. D Carden F Xiao C Moak, et al. 1998 Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins Am J Physiol 275 H385 H392 9683424 1:CAS:528:DyaK1cXlsVOqu7s%3D
11. TJ Moraes CW Chow GP Downey 2003 Proteases and lung injury Crit Care Med 31 S189 S194 12682439 10.1097/01.CCM.0000057842.90746.1E 1:CAS:528: DC%2BD3sXis12qtLw%3D
12. BG Zeiher A Artigas JL Vincent, et al. 2004 Neutrophil elastase inhibition in acute lung injury: results of the strive study Crit Care Med 32 1695 1702 15286546 10.1097/01.CCM.0000133332.48386.85 1:CAS:528: DC%2BD2cXmtFCgtLs%3D (Pubitemid 39050520)
13. H Shimada T Ochiai S Okazumi, et al. 2000 Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer Surgery 128 791 798 11056442 10.1067/msy.2000.108614 1:STN:280:DC%2BD3M%2FjsFGktg%3D%3D
14. K Kawabata M Suzuki M Sugitani, et al. 1991 Ono-5046, a novel inhibitor of human neutrophil elastase Biochem Biophys Res Commun 177 814 820 2049103 10.1016/0006-291X(91)91862-7 1:CAS:528:DyaK3MXksVWqt7g%3D
15. K Matsuzaki Y Hiramatsu S Homma, et al. 2005 Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation Ann Thorac Surg 80 611 617 16039215 10.1016/j.athoracsur.2005.02.038 (Pubitemid 41019490)
16. K Suda Y Kitagawa S Ozawa, et al. 2007 Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy Dis Esophagus 20 478 486 17958722 10.1111/j.1442-2050.2007.00699.x 1:STN:280:DC%2BD2snjsV2hsQ%3D%3D (Pubitemid 47617831)
17. S Tamakuma M Ogawa N Aikawa, et al. 2004 Relationship between neutrophil elastase and acute lung injury in humans Pulm Pharmacol Ther 17 271 279 15477122 10.1016/j.pupt.2004.05.003 1:CAS:528:DC%2BD2cXotlSlurc%3D (Pubitemid 39345408)
18. S Ono H Tsujimoto S Hiraki, et al. 2007 Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy World J Surg 31 1996 2001 17674097 10.1007/s00268-007-9172-6 (Pubitemid 47415716)
19. Y Kawahara I Ninomiya T Fujimura, et al. 2009 Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer Dis Esophagus 23 329 339 19788440 10.1111/j.1442-2050.2009.01010.x
20. F Lin CM Nguyen SJ Wang, et al. 2004 Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration Biochem Biophys Res Commun 319 576 581 15178445 10.1016/j.bbrc.2004.05.029 1:CAS:528:DC%2BD2cXkslSjurg%3D (Pubitemid 38725985)